AADI Bioscience AADI Bioscience AADI Bioscience
Navigation
  • The Company
  • Our Science
    • mTOR Pathway
    • nab Technology Platform
    • Publications and Abstracts
  • Our Medicine
    • Our Medicine
    • Advanced Malignant PEComa
  • Pipeline
  • Expanded Access
  • Patients
    • Overview
    • Patient Advocacy
  • Contact Us
    • General Contact
    • For Healthcare Professionals
    • Careers

Latest News

0   0
by / / Uncategorized
  • Previous
  • 1
  • ...
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next

Recent Articles

  • David Dornan, PhD
  • Baiteng Zhao, PhD
  • Characterizing the genomic landscape of malignant perivascular epithelioid cell family of tumors (PEComa-FT) in a real-world population using the Foundation Medicine genomic database
  • A Phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
  • Antitumor activity of nab-sirolimus versus mTOR inhibitors temsirolimus, sirolimus, and everolimus in A549 NSCLC xenografts
  • Home
  • Pipeline
  • Patients
  • Contact
  • Careers
  • Terms & Conditions
  • Privacy